Danaher Corporation (DHR) Stake Raised by HPM Partners LLC

HPM Partners LLC grew its position in Danaher Corporation (NYSE:DHR) by 4.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 78,876 shares of the conglomerate’s stock after acquiring an additional 3,553 shares during the quarter. HPM Partners LLC’s holdings in Danaher Corporation were worth $6,346,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently made changes to their positions in DHR. Waldron LP purchased a new stake in shares of Danaher Corporation in the first quarter valued at $320,000. Empire Life Investments Inc. raised its stake in shares of Danaher Corporation by 2.3% in the first quarter. Empire Life Investments Inc. now owns 77,900 shares of the conglomerate’s stock valued at $6,662,000 after acquiring an additional 1,764 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Danaher Corporation by 4.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 355,219 shares of the conglomerate’s stock valued at $30,382,000 after acquiring an additional 14,462 shares during the period. Assenagon Asset Management S.A. purchased a new stake in shares of Danaher Corporation in the first quarter valued at $648,000. Finally, Swiss National Bank raised its stake in shares of Danaher Corporation by 24.0% in the first quarter. Swiss National Bank now owns 2,569,144 shares of the conglomerate’s stock valued at $219,739,000 after acquiring an additional 496,900 shares during the period. 75.69% of the stock is currently owned by institutional investors and hedge funds.

In other Danaher Corporation news, insider William King sold 43,688 shares of the business’s stock in a transaction dated Thursday, August 31st. The shares were sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the sale, the insider now directly owns 45,748 shares in the company, valued at $3,790,679.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Linda P. Hefner sold 10,578 shares of the business’s stock in a transaction dated Friday, July 21st. The stock was sold at an average price of $83.03, for a total transaction of $878,291.34. Following the sale, the director now owns 42,151 shares in the company, valued at $3,499,797.53. The disclosure for this sale can be found here. Insiders have sold 71,496 shares of company stock worth $5,916,223 over the last quarter. Insiders own 12.20% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Danaher Corporation (DHR) Stake Raised by HPM Partners LLC” was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at https://www.com-unik.info/2017/10/13/danaher-corporation-dhr-stake-raised-by-hpm-partners-llc.html.

Danaher Corporation (DHR) opened at 87.03 on Friday. Danaher Corporation has a one year low of $75.71 and a one year high of $88.62. The company has a market capitalization of $60.46 billion, a PE ratio of 27.78 and a beta of 1.03. The firm’s 50-day moving average is $85.70 and its 200 day moving average is $84.21.

Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. Danaher Corporation’s revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.90 EPS. On average, equities analysts expect that Danaher Corporation will post $3.96 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be paid a dividend of $0.14 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.64%. Danaher Corporation’s dividend payout ratio (DPR) is presently 17.83%.

Several equities research analysts have recently weighed in on the stock. Wells Fargo & Company reissued a “market perform” rating on shares of Danaher Corporation in a research note on Saturday, July 22nd. Cowen and Company reissued a “buy” rating and issued a $90.00 target price on shares of Danaher Corporation in a research note on Wednesday, October 4th. Jefferies Group LLC reissued a “buy” rating and issued a $95.00 target price on shares of Danaher Corporation in a research note on Friday, August 4th. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, July 25th. Finally, Morgan Stanley reissued an “overweight” rating and issued a $95.00 target price (up previously from $86.00) on shares of Danaher Corporation in a research note on Friday, October 6th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $92.62.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

What are top analysts saying about Danaher Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Danaher Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit